Atrion Corporation Inc. (ATRI) Price to Earnings Ratio

Atrion Corp - graphic logo of issuer ATRI

Atrion Corporation (ATRI) specializes in the production of niche components for ophthalmological and cardiological procedures protected by complex certifications. The company is currently finalizing a merger with a large holding, fully integrating its capacities into the new owner's structure. However, raw material volatility and pressure from Eastern markets remain threats, and the indicator stands at 65.30. The share price history on GURU.Markets clearly demonstrates these market trends.

Atrion (ATRI) - P/E Multiple from 07/04/2022 to 08/31/2024

Analytical breakdowns for Atrion Corporation

- price and consensus price forecast:
General company analysis:Atrion Corp., ATRI
Product sample of Atrion Corporation

The P/E ratio measures the market value of a single unit of profit, transforming quarterly reports into a continuous stream of business valuation. For Atrion Corporation (ATRI), this multiple reflects a premium for the high switching costs B2B clients face when moving away from their integrated medical systems. By analyzing the P/E ratio dynamics of Atrion Corporation (ATRI) on GURU.Markets, an investor can observe the actual balance between supply and demand. This indicator makes it possible to identify asset overvaluation, while the resulting curve determines the fundamental attractiveness of the shares.

Analysis of competing companies

P/E Multiple Intuitive Surgical, Inc.|Price to Earnings Ratio DHR (Danaher Corp)|BDX (Becton, Dickinson and Company) - Company Value to Net Income|P/E Multiple STE (steris.com)|Business Payback Period westpharma.com (WST)|BAX - Price to Earnings Ratio|Business Payback Period Masimo Corp MASI|Stevanato Group S.p.A. (STVN) - Price to Earnings Ratio|TFX - Business Payback Period|Price to Earnings Ratio merit.com|Envista (NVST) - Business Payback Period|Price to Earnings Ratio ICUI (ICU Medical, Inc.)|Market Price to Net Income Ratio XRAY|Price to Earnings Ratio LeMaitre LMAT|Company Value to Net Income ATRC|STAA: Price to Earnings Ratio|NAGE - P/E Multiple|ZimVie Inc (ZIMV) - Price to Earnings Ratio|Price to Earnings Ratio AngioDynamics|CERS (cerus.com) - P/E Multiple|Market Cap to Earnings Teknova Inc TKNO|Price to Earnings Ratio Monogram Orthopedics (MGRM)|Sharps Tech - Price to Earnings Multiple|InfuSystem Holdings, Inc. - Price to Earnings Ratio|Market Price to Net Income Ratio UTMD (Utah Medical Products Inc.)|KRMD - Price to Earnings Ratio|Business Payback Period Nyxoah S.A NYXH|microbotmedical.com (MBOT) - Price to Earnings Ratio|Market Cap to Net Income PDEX (pro-dex.com)|ZTEK (Zentek Corp) - P/E Multiple|Price to Earnings Ratio ELUT|Price to Earnings Ratio Milestone Scientific Corp (MLSS)|NEXGEL, Inc - Price to Earnings Multiple|P/E Multiple RVP (Retractable Technologies Inc.)|Harvard Bioscience, Inc. - Price to Earnings Ratio|FEMY - Price to Earnings Ratio|MHUA - P/E Multiple|POAI: P/E Multiple|Price to Earnings Multiple CJMB|NURO (NeuroMetrix Inc) - P/E Multiple